INCREASE IN RENAL CYTOCHROME-P-450 AND NADPH CYTOCHROME-C REDUCTASE-ACTIVITY FOLLOWING DRUG-INHIBITION OF HEPATIC MONOOXYGENASE ACTIVITY

被引：8
作者：
BARRY, M
DUENASLAITA, A
MACMATHUNA, P
FEELY, J
机构：
来源：
BIOCHEMICAL PHARMACOLOGY | 1987年 / 36卷 / 05期
关键词：
D O I：
10.1016/0006-2952(87)90732-5
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：768 / 769
页数：2
相关论文
共 15 条
  • [1] REGULATION OF RENAL CYTOCHROME-P-450 - EFFECTS OF 2/3 HEPATECTOMY, CHOLESTASIS, BILIARY-CIRRHOSIS AND POST-NECROTIC CIRRHOSIS ON HEPATIC AND RENAL MICROSOMAL-ENZYMES
    BABANY, G
    DESCATOIRE, V
    CORBIC, M
    GENDRE, S
    DEGOTT, C
    LARREY, D
    LETTERON, P
    WANDSCHEER, JC
    FUNCKBRENTANO, C
    PESSAYRE, D
    [J]. BIOCHEMICAL PHARMACOLOGY, 1985, 34 (03) : 311 - 320
  • [2] MONO-OXYGENASE ACTIVITY OF HUMAN-LIVER IN MICROSOMAL FRACTIONS OF NEEDLE-BIOPSY SPECIMENS
    BOOBIS, AR
    BRODIE, MJ
    KAHN, GC
    FLETCHER, DR
    SAUNDERS, JH
    DAVIES, DS
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (01) : 11 - 19
  • [3] GRECHBELANGER O, 1984, RES COMMUN CHEM PATH, V44, P15
  • [4] HIETANEN W, 1985, DRUG METABOLISM, P141
  • [5] AMIODARONE PHARMACOKINETICS
    HOLT, DW
    TUCKER, GT
    JACKSON, PR
    STOREY, GCA
    [J]. AMERICAN HEART JOURNAL, 1983, 106 (04) : 840 - 847
  • [6] HOLT DW, 1984, BRIT J CLIN PHARMACO, V17, pP195
  • [7] JAKOBSSO.SV, 1973, J PHARMACOL EXP THER, V185, P226
  • [8] JENNER P, 1976, DRUG METABOLISM CHEM, P445
  • [9] LOWRY OH, 1951, J BIOL CHEM, V193, P265
  • [10] MAZEL P, 1971, FUNDAMENTALS DRUG ME, P546
12